PTC Therapeutics receives FDA approval for PKU treatment drug
Go back to PTC Therapeutics receives FDA approval for PKU treatment drug| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 67.05 -0.32 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.37 | 52 Week High | $35.40 | |||
| Open | $67.80 | 52 Week Low | $4.03 | |||
| Day High | $68.48 | P/E | 7.13 | |||
| Day Low | $67.05 | EPS | $9.40 | |||
| Volume | 89,090 | |||||
